关于开云体育数据中心：全球首创3D生物血管打印机在成都问世，下面从多个角度归纳核心要点，方便读者快速参考。The creative breakthrough in the 3D blood vessel bio-printing means we have mastered the stem cell-based 3D bio-printing technology, said Yang Keng, chairman of Sichuan Languang Development Co., Ltd. Revotek is a subsidiary of Sichuan Languang.四川蓝光发展公司主席杨铿说道，“这一具备创新性的3D血管印刷机的发明者，意味著我们早已掌控了干细胞为基础的3D生物打印机技术”。Revotek是四川蓝光集团的子公司。

Blood vessels that transport nutrients to organs are indispensable elements when creating any organs, according to James Kang, an expert who led the program.据领导该项目的专家James Kang说道，当建构任何器官的时候，向各器官载运营养物质的血管是必不可少的。Kangs team has created a novel type of bio-ink - Biosynsphere, whose primary goal is the personalized stem cell bio-printing to pave the way for organ regeneration.康的研发团队早已建构了一个新的生物链接模式- Biosynsphere，这一链接模式的首要目标是个体干细胞生物打印机，以便器官再造。

We have successfully realized the blood vessel regeneration by relying on the 3D bio-printer, the biosynsphere technology and the data model based on cloud computing, he said.他说道，“我们早已顺利地依托倚赖3D打印机，biosynsphere技术和云计算基础上的数据模型构建了血管再造。”The company said it is willing to absorb more talent and seek international cooperation for the application of the achievements.公司很不愿吸取更好的人才并且谋求国际公司来应用于这一成就。A Chinese biotechnological company announced on Sunday it has developed the worlds first 3D blood vessel bio-printer, which makes it possible to produce personalized functional organs.本周日，中国的一家生物技术公司宣告，它早已研发出有了世界上第一台3D血管生物打印机，这使得生产个体功能器官沦为有可能。

Sichuan Revotek Co., Ltd. based in Chengdu, capital of southwest Chinas Sichuan Province, said the significant breakthrough has been achieved through its self-developed stem cell bio-ink technology, 3D bio-printer and cloud computing platform.坐落于中国西南部四川省省会成都的四川Revotek公司称之为，通过公司自己研发的干细胞生物相连技术、3D生物打印机和云计算平台，3D血管生物打印机这一具备划时代的意义的技术突破早已已完成。整体来看，开云体育数据中心：全球首创3D生物血管打印机在成都问世的相关信息仍值得持续留意。

本文来源：开云体育官网-www.express-kaiyun.com.cn